Diagnostic and clinical relevance of the number of circulating CD34+ cells in myelofibrosis with myeloid metaplasia

Blood

Volumn 98, Issue 12, 2001, Pages 3249-3255

  Barosi, Giovanni ^a,b,c   Viarengo, Gianluca ^a,b,c   Pecci, Alessandro ^a,b,c   Rosti, Vittorio ^a,b,c   Piaggio, Giovanna ^a,b,c   Marchetti, Monia ^a,b,c   Frassoni, Francesco ^a,b,c  

^a Laboratory of Medical Informatics   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ADULT; AGED; ARTICLE; BLAST TRANSFORMATION; BONE MARROW CELL; CELL COUNT; CELL SURVIVAL; DIAGNOSTIC TEST; FEMALE; HUMAN; HUMAN CELL; LIVER WEIGHT; MAJOR CLINICAL STUDY; MALE; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; SPLEEN;

EID: 0035760303     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.12.3249     Document Type: Article

References (29)

1. Partanen S, Ruutu T, Vuopio P. Circulating haematopoietic progenitors in myelofibrosis. Scand J Haematol. 1982;29:325-330.
2. Douer D, Fabian I, Cline MJ. Circulating pluripotent haemopoietic cells in patients with myeloproliferative disorders. Br J Haematol. 1983;54:373-381.
3. Wang JC, Cheung CP, Ahmed F, et al. Circulating granulocyte and macrophage progenitor cells in primary and secondary myelofibrosis. Br J Haematol. 1983;54:301-307.
4. Hibbin JA, Njoku OS, Matures E, et al. Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders. Br J Haematol. 1984;57:495-503.
5. Charbord P, Leberec D. Granulomonocytic colony forming cells in myelofibrosis: concentrations within hepatic blood and peripheral blood. Leuk Res. 1985;9:1267-1270.
6. Carlo-Stella C, Cazzola M, Gasner A, et al. Effects of recombinant alpha and gamma interferons on in vitro growth of circulating hemopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM) from patients with myelofibrosis with myeloid metaplasia. Blood. 1987;70:1014-1019.
7. Douay L, Laporte JP, Lefrancois G, et al. Blood and spleen hematopoiesis in patients with myelofibrosis. Leuk Res. 1987;11:725-730.
8. Han ZC, Brière J, Nedellec G, et al. Characteristics of circulating megakaryocyte progenitors (CFU-MK) in patients with primary myelofibrosis. Eur J Haematol. 1988;40:130-135.
9. Colovic MD, Wiernik PH, Jankovic GM, Vidovic AD, Janosevic S, Basara NM. Circulating haemopoietic progenitor cells in primary and secondary myelofibrosis: relation to collagen and reticulin fibrosis. Eur J Haematol. 1999;62:155-159.
10. Andreasson B, Swolin B, Kutti J. Increase of CD34 positive cells in polycythaemia vera. Eur J Haematol. 1997;59:171-176
11. Andreasson B, Swolin B, Kutti J. Hydroxyurea treatment reduces haematopoietic progenitor growth and CD34 positive cells in polycythaemia vera and essential thrombocythaemia. Eur J Haematol. 2000;64:188-193.
12. Taksin AL, Le Couedic J-P, Dusanter-Fourt I, et al. Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L. Blood. 1999;93:125-139.
13. Barosi G. Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines. J Clin Oncol. 1999;17:2954-2970.
14. Barosi G, Ambrosetti A, Finelli C, et al. The Italian Consensus Conference on diagnostic criteria for myelofibrosis with myeloid metaplasia. Br J Haematol. 1999;104:730-737.
15. Goulis J, Chau TN, Jordan S, et al. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut. 1999;44:754-758.
16. Dupriez B, Morel P, Demory JL, et al. Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood. 1996;88:1013-1018.
17. Berlin NI. Diagnosis and classification of the polycythemias. Semin Hematol. 1975;12:339-351.
18. Murphy S, Iland H, Rosenthal D, Laszlo J. Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol. 1986;23:177-182.
19. Barosi G, Buratti A, Costa A, et al. An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression. Cancer. 1991;68:2310-2318.
20. Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry. 1998;34:61-70.
21. Omedé P, Borgialli R, Sormano E, et al. Multicentric quality control trial for CD34+ cells evaluation in peripheral blood and leukapheresis collection from patients with hematological malignancies. Eur J Histochem. 1997;41(suppl 2):35-36.
22. Zweig MH, Campell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39:561-577.
23. Andrews RG, Singer JW, Bernstein ID. Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of CD33 and CD34 antigens and light scattering properties. J Exp Med. 1989;169:1721-1731.
24. Novelli EM, Ramirez M, Civin CI. Biology of CD34+CD38- cells in lymphohematopoiesis. Leuk Lymphoma. 1998;31:285-293.
25. Fuchigami K, Mori H, Matsuo T, et al. Absolute number of circulating CD34+ cells is abnormally low in refractory anemias and extremely high in RAEB and RAEB-t; novel pathologic features of myelodysplastic syndromes identified by highly sensitive flow cytometry. Leuk Res. 2000;24:163-174.
26. Sullivan SA, Marsden KA, Lowenthal RM, Jupe DM, Jones ME. Circulating CD34+ cells: an adverse prognostic factor in the myelodysplastic syndromes. Am J Hematol. 1992;39:96-101.
27. Buyssens N, Bourgeois NH. Chronic myelocytic leukemia versus idiopathic myelofibrosis: a diagnostic problem in bone marrow biopsies. Cancer. 1977;40:1548-1561.
28. Barosi G, Cazzola M, Frassoni F, Orlandi E, Stefanelli M. Erythropoiesis in myelofibrosis with myeloiod metaplasia: recognition of different classes of patients by erythrokinetics. Br J Haematol. 1981;48:263-272.
29. Mesa RA, Hanson CA, Rajkumar SV, Schroeder G, Tefferi A. Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia. Blood. 2000;96:3374-3380.